← All diseases Cancer

Chronic lymphocytic leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (63)Meta-analysis (7)Treatment guideline (3)Phase 3 study (32)Systematic review (13)Randomized trial (8)Clinical trial (588)Review article (208)Early study (phase 1 or 2) (38)Case report (197)Laboratory or animal study (14)Commentary or editorial (62)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (1769)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Stable improvement in classical B-cell chronic lymphocytic leukemia with dietary interventions: A personal experience. (2020/09/14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. (2020/09/01) ♡
• A Study Investigating the Role of 2 Candidate SNPs in Bax and Bcl-2 Genes in Alzheimer's Disease. (2020/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report. (2020/09/01) ♡
• Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting. (2020/09/01) ♡
• Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting: commentary. (2020/09/01) ♡
• Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development. (2020/08/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic lymphocytic leukemia skin infiltrates presenting as eyebrow alopecia and erythematous pruritic papules refractory to treatment with topical steroids. (2020/08/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Subglottic stenosis due to chronic lymphocytic leukemia. (2020/07/01) ♡
• Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity. (2020/06/18) ♡
• A Scoping Review of Interactions between Omega-3 Long-Chain Polyunsaturated Fatty Acids and Genetic Variation in Relation to Cancer Risk. (2020/06/02) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features. (2020/06/01) ♡
• The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment. (2020/06/01) ♡
• Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases. (2020/06/01) ♡
• The evolving use of minimal residual disease (MRD) assessment in chronic lymphocytic leukemia. (2020/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A clinical perspective on minimal residual disease (MRD) assessment in chronic lymphocytic leukemia. (2020/06/01) ♡
• Assessment of minimal residual disease (MRD) in chronic lymphocytic leukemia: a review of the data and future directions. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The evolving use of minimal residual disease (MRD) assessment in chronic lymphocytic leukemia: Q&A. (2020/06/01) ♡
• Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. (2020/06/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059). (2020/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses. (2020/05/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report. (2020/05/01) ♡
• Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells. (2020/04/01) ♡
• Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prospects for Venetoclax in Myelodysplastic Syndromes. (2020/04/01) ♡
• The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. (2020/04/01) ♡
• Ellagitannins from Punica granatum leaves suppress microsomal prostaglandin E synthase-1 expression and induce lung cancer cells to undergo apoptosis. (2020/04/01) ♡
• Improving Outcomes for Patients With Chronic Lymphocytic Leukemia. (2020/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rare case of Richter's syndrome localization in liver and thyroid of a patient with a chronic lymphocytic leukemia (CLL) - Case report and literature. (2020/03/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program. (2020/03/16) ♡
• Oxidative stress in CLL patients leads to activation of Th9 cells: an experimental and comprehensive survey. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myelin uncompaction and axo-glial detachment in chronic ataxic neuropathy with monospecific IgM antibody to ganglioside GD1b. (2020/03/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Comparison of three oral selenium compounds in cancer patients: Evaluation of differential pharmacodynamic effects in normal and malignant cells. (2020/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Practical management of tumour lysis syndrome in venetoclax-treated patients with chronic lymphocytic leukaemia. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thoracic aortic dissection associated with involvement by small lymphocytic lymphoma/chronic lymphocytic leukemia: a possible underappreciated risk factor? (2020/03/01) ♡
• Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib. (2020/03/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Residential exposure to petrochemical industrial complexes and the risk of leukemia: A systematic review and exposure-response meta-analysis. (2020/03/01) ♡
• Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry. (2020/03/01) ♡
• Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring. (2020/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Activation-induced T-cell exhaustion: too much of a good thing? (2020/02/01) ♡
• 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia. (2020/02/01) ♡
• Implementation of a classification strategy of Raman data collected in different clinical conditions: application to the diagnosis of chronic lymphocytic leukemia. (2020/02/01) ♡
• Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015. (2020/02/01) ♡
• PRIMA-1(MET) cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells. (2020/02/01) ♡
• Myopathies presenting with head drop: Clinical spectrum and treatment outcomes. (2020/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study. (2020/02/01) ♡
• Genetically Determined Height and Risk of Non-hodgkin Lymphoma. (2020/01/28) ♡
• Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells. (2020/01/25) ♡
• Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival. (2020/01/15) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.